TD Cowen Lifts CVS Health Corporation (CVS) Price Target amid Record Q3 Revenue

CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy now. On November 3, 2025, TD Cowen lifted its price target on the stock to $100 from $99, while keeping a Buy rating. The move followed management’s updated guidance, which narrowed the expected GAAP diluted loss per share to between $0.24 and $0.34, down sharply from the earlier forecast of $3.84 to $3.94. At the same time, adjusted earnings guidance was raised to $6.55–$6.65 per share, compared with the prior range of $6.30–$6.40.

Just days earlier, on October 29, 2025, CVS Health Corporation reported third‑quarter revenue of $102.9 billion, a 7.8% increase from the previous year and well above the consensus estimate of $98.88 billion.

The company posted a diluted loss per share of $3.13, largely the result of a $5.7 billion goodwill impairment charge tied to its Healthcare Delivery unit. On an adjusted basis, earnings came in at $1.60 per share, up from $1.09 a year earlier, supported by stronger operating income in the Health Care Benefits segment.

“Our leadership team has stabilized operations and is focused on businesses and markets where we can succeed. As a result, we are making progress on our journey to be America’s most trusted health care company. Our strong Enterprise performance demonstrates the continued focus we have on operational and financial improvement across our businesses,” said CEO David Joyner.

CVS Health Corporation (NYSE:CVS) is a healthcare company that operates an integrated healthcare model across several sectors, including pharmacy, retail, health insurance, and pharmacy benefit management.

While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 9 Undervalued Asset Management Stocks to Buy and 13 Best AI Stocks to Buy Under $20.

Disclosure: None. This article is originally published at Insider Monkey.